Financial News
Seelos Therapeutics Inc (NQ: SEEL )
0.3125
-0.0176
(-5.33%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Press Releases about Seelos Therapeutics Inc
Mind Science Targeting Big Brains and Portfolios
August 02, 2023
Via AB Newswire
Psychedelics Are Proving Their Mettle Against Trauma, Anxiety
February 13, 2023
Topics
Cannabis
Exposures
Cannabis
![](https://pressreach.com/wp-content/uploads/2022/10/realcg-1.jpg)
Colorado to Vote on Legalizing Psychoactives in November
October 05, 2022
Via PressReach
Topics
Supply Chain
Exposures
Supply Chain
![](https://pressreach.com/wp-content/uploads/2022/10/Depositphotos_282649386_s-2019.jpg)
Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer’s Disease
October 05, 2022
Via PressReach
Topics
Cannabis
Exposures
Cannabis
Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer’s Disease
October 05, 2022
Topics
Cannabis
Exposures
Cannabis
Psychedelics Use Among Young Adults Reaches All-Time High
September 01, 2022
Exposures
Derivatives
Psychedelics Offer Hope for Mental Disorders, Addiction
November 03, 2021
Rising Acceptance For Treating Mental Disorders is Fueling Strong Growth in Psychedelic Drugs Market
October 14, 2021
Exposures
COVID-19
Psychedelics Gain More Traction as New Research Aims to Address Chronic Pain and Mental Illness
July 21, 2021
Topics
Law Enforcement
Exposures
Legal
Increased R&D Activities Have Fueled Growth and Promise for Pancreatic Cancer Treatment
May 20, 2021
Topics
Death
Exposures
Death
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.